Palbociclib in Combination With Adjuvant Endocrine Therapy for Hormone Receptor Positive, HER2 Negative Invasive Breast Cancer
Clinical trial NCT02040857 · COMPLETED
Trial details
- NCT number
- NCT02040857
- Sponsor
- Dana-Farber Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-01
- Primary completion
- 2018-05-01
- Enrollment
- 162
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.